Dendritic cells and cytokines in immune rejection of cancer

被引：47

作者：

Ferrantini, Maria ^{[1
]}

Capone, Imerio ^{[1
]}

Belardelli, Filippo ^{[1
]}

机构：

[1] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy

来源：

CYTOKINE & GROWTH FACTOR REVIEWS | 2008年 / 19卷 / 01期

关键词：

dendritic cells; cytokines; immune potentiators; cancer immunity; immunotherapy;

D O I：

10.1016/j.cytogfr.2007.10.003

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Dendritic cells (DCs) play a crucial role in linking innate and adaptive immunity and, thus, in the generation of a protective immune response against both infectious diseases and tumors. The ability of DCs to prime and expand an immune response is regulated by signals acting through soluble mediators, mainly cytokines and chemokines. Understanding how cytokines influence DC functions and orchestrate the interactions of DCs with other immune cells is strictly instrumental to the progress in cancer immunotherapy. Herein, we will illustrate how certain cytokines and immune stimulating molecules can induce and sustain the antitumor immune response by acting on DCs. We will also discuss these cytokine-DC interactions in the light of clinical results in cancer patients. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：93 / 107

页数：15

共 145 条

[71] Imiquimod is a strong inhibitor of tumor cell-induced angiogenesis [J].

Majewski, S ;

Marczak, M ;

Mlynarczyk, B ;

Benninghoff, B ;

Jablonska, S .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2005, 44 (01) :14-19

[72] The danger model: A renewed sense of self [J].

Matzinger, P .

SCIENCE, 2002, 296 (5566) :301-305

[73]

McCluskie MJ, 2006, CURR TOP MICROBIOL, V311, P155

[74] Optimizing dendritic cell-based anticancer immunotherapy: maturation state does have clinical impact [J].

McIlroy, D ;

Gregoire, M .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (10) :583-591

[75] Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod [J].

Michalopoulos, P ;

Yawalkar, N ;

Brönnimann, M ;

Kappeler, A ;

Braathen, LR .

BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (04) :903-906

[76] Increased TIA-1 gene expression in the tumor microenvironment after locoregional administration of tumor necrosis factor-α to patients with soft tissue limb sarcoma [J].

Mocellin, S ;

Provenzano, M ;

Lise, A ;

Nitti, D ;

Rossi, CR .

INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (02) :317-322

[77] Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients [J].

Molenkamp, Barbara G. ;

van Leeuwen, Paul A. M. ;

Meijer, Sybren ;

Sluijter, Berbel J. R. ;

Wijnands, Pepijn G. J. T. B. ;

Baars, Arnold ;

van den Eertwegh, Alfons J. M. ;

Scheper, Rik J. ;

de Grujil, Tanja D. .

CLINICAL CANCER RESEARCH, 2007, 13 (10) :2961-2969

[78] Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia [J].

Molldrem, JJ ;

Lee, PP ;

Wang, CQ ;

Felio, K ;

Kantarjian, HM ;

Champlin, RE ;

Davis, MM .

NATURE MEDICINE, 2000, 6 (09) :1018-1023

[79] Dendritic cells under the spell of prostaglandins [J].

Morelli, AE ;

Thomson, AW .

TRENDS IN IMMUNOLOGY, 2003, 24 (03) :108-111

[80] The role of IL-13 in the generation of dendritic cells in vitro [J].

Morse, MA ;

Lyerly, HK ;

Li, YW .

JOURNAL OF IMMUNOTHERAPY, 1999, 22 (06) :506-513

← 3 4 5 6 7 8 9 10 11 12 →